Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer.
The goal of this study was to identify prognostic factors of survival in patients receiving palliative external-beam radiotherapy (EBRT) for advanced liver cancer. Seventeen patients irradiated for advanced liver cancer were retrospectively evaluated. Fourteen patients had metastatic disease, three had locally advanced disease. Six variables were investigated for survival: age at EBRT, time from liver cancer diagnosis to EBRT, number of involved metastatic sites, gender, Eastern Cooperative Oncology Group (ECOG) performance score, radiation dose. On univariate analyses, time from liver cancer diagnosis to EBRT >12 months (p=0.040), only 0-1 metastatic sites (p=0.003) and ECOG performance score 1-2 (p<0.001) were positively correlated with survival. On Cox regression analysis, the number of metastatic sites (risk ratio=4.68, p=0.053) and ECOG performance score (risk ratio=4.68, p=0.056) showed a strong trend for association with survival. Predictors of survival were found that can facilitate choosing the optimal treatment for individual patients with liver cancer assigned to palliative EBRT.